WISC014i-SC1

This cell line is a modified version of WISC011i-inGFPpuro, engineered using CRISPR/Cas9 with dual gRNA to edit the CCR5 gene. This cell line may be used to study of the role of CCR5 in HIV infection in vitro, and generation of HIV-resistant cells for potential therapeutic applications.
Cell Line Alias GFP-CCR5mut-hiPSC-Comb2-SC1
Cell Type Modified Human iPS
Disease None reported
Genetic Alteration/Mutation CCR5
Genetic Alteration/Mutation Information Biallelic 551bp deletion in CCR5 gene.
Genetic Modification Keyword Isogenic; HIV
Sex Male
Ethnicity African American > Nigerian
Genetically Related Cell Lines  
Reprogramming Method CRISPR/CAS9 technology using Addgene Plasmid ID 43861: mammalian codon optimized Cas9 nuclease (JDS246) Addgene Plasmid ID 43860: guide RNA (gRNA) expression vector
Provider University of Wisconsin - Dr. Igor Slukvin
dbGaP Data  
hPSCReg ID  
NIH Approval  
Pub Med Abstract  
Related Products
Have you received this cell line previously? Yes No Why we ask
Quantity: Learn about our volume discounts

Current Lot Information

Lot Number Culture Platform Lot Description Passage Number Banked By Protocol Product Information & Testing
WB66706 TeSR-E8/Matrigel   53 WiCell WiCell Feeder Independent Pluripotent Stem Cell Protocol PDF